Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
Neural Regen Res
.
2021 Mar;16(3):508-509.
doi: 10.4103/1673-5374.293146.
Authors
Timothy J Kopper
1
,
John C Gensel
1
Affiliation
1
Spinal Cord and Brain Injury Research Center, Department of Physiology, University of Kentucky, Lexington, KY, USA.
PMID:
32985477
PMCID:
PMC7996014
DOI:
10.4103/1673-5374.293146
No abstract available
Grants and funding
F31 NS105443/NS/NINDS NIH HHS/United States
R01 NS091582/NS/NINDS NIH HHS/United States